Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials
暂无分享,去创建一个
Tim Ramsay | T. Ramsay | J. Kimmelman | B. Carlisle | Nathalie Mackinnon | Jonathan Kimmelman | Benjamin Carlisle | Nathalie MacKinnon
[1] G. Helgesson,et al. Early Stopping of Clinical Trials: Charting the Ethical Terrain , 2011, Kennedy Institute of Ethics journal.
[2] R. Prescott,et al. Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.
[3] Scott D Ramsey,et al. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. , 2010, Journal of the National Cancer Institute.
[4] D. Dilts,et al. A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies , 2010, Clinical Cancer Research.
[5] A. Smyth,et al. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study , 2012, BMJ : British Medical Journal.
[6] B. Freidlin,et al. Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Arianne P Verhagen,et al. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. , 2007, Journal of clinical epidemiology.
[8] M. Peters-Lawrence,et al. Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial. , 2012, Contemporary clinical trials.
[9] K. Gelmon,et al. Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Keen,et al. Early closure of European Pimagedine trial , 1997, The Lancet.
[11] R. Gray,et al. Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups , 2011, Clinical Cancer Research.
[12] R. Bilous,et al. Early closure of European Pimagedine trial. Steering Committee. Safety Committee. , 1997, Lancet.
[13] Being ‘underpowered’ does not make a study unethical , 2012, Statistics in medicine.
[14] L. Sjöström,et al. Principles for enhanced recruitment of subjects in a large clinical trial. the XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study experience. , 2001, Controlled clinical trials.
[15] J. Karlawish,et al. The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.